+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Topical treatment of cutaneous leishmaniasis in Belize: in vitro and in vivo studies with Leishmania mexicana



Topical treatment of cutaneous leishmaniasis in Belize: in vitro and in vivo studies with Leishmania mexicana



International Journal for Parasitology 23(1): 121-127



Strains of Leishmania mexicana isolated from Belizian patients were found to be highly susceptible to paromomycin sulphate (PR) treatment. This drug at 100 micrograms ml-1 destroyed 85-99.5% of in vitro cultivated Leishmania promastigotes within 4 days of exposure to the drug. Leishmania promastigotes inoculated into the base of the tail of Balb/c mice caused the development of local lesions several weeks after infection. These lesions were totally cleared of parasites after 20 days of topical treatment with PR ointment, comprised of 15% paromomycin sulphate and 12% methylbenzethonium chloride in soft white paraffin. Similar results were also obtained with L. braziliensis infections. Isoenzyme analysis was found to be the method of choice for parasite strain identification. Excreted factor serotyping was only partially effective and promastigote agglutination gave negative results.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 009654546

Download citation: RISBibTeXText

PMID: 8468127

DOI: 10.1016/0020-7519(93)90104-7


Related references

Pentalinon andrieuxii root extract is effective in the topical treatment of cutaneous leishmaniasis caused by Leishmania mexicana. PhytoTherapy Research 28(6): 909-916, 2014

Topical treatment with nanoliposomal Amphotericin B reduces early lesion growth but fails to induce cure in an experimental model of cutaneous leishmaniasis caused by Leishmania mexicana. Acta Tropica 173: 102-108, 2017

Draft Genome Sequences of Leishmania ( Leishmania ) amazonensis , Leishmania ( Leishmania ) mexicana , and Leishmania ( Leishmania ) aethiopica , Potential Etiological Agents of Diffuse Cutaneous Leishmaniasis. Microbiology Resource Announcements 8(20):, 2019

Case report: Transient success using prolonged treatment with miltefosine for a patient with diffuse cutaneous leishmaniasis infected with Leishmania mexicana mexicana. American Journal of Tropical Medicine and Hygiene 88(1): 153-156, 2013

Studies on the immunology and serology of leishmaniasis. 3. on the cross-immunity between Panamanian cutaneous leishmaniasis and Leishmania mexicana infection in man. Transactions of the Royal Society of Tropical Medicine and Hygiene 60(4): 533-535, 1966

Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment. American Journal of Tropical Medicine and Hygiene 75(6): 1074-1077, 2006

Experimental cutaneous leishmaniasis. 3. Comparative pathology of infection by Leishmania brazilensis, Leishmania mexicana, and Leishmania tropica in laboratory animals. Revista do Instituto de Medicina Tropical de Sao Paulo 14(1): 12-29, 1972

Molecular karyotype characterization of Leishmania panamensis, Leishmania mexicana, and Leishmania major-like parasites: agents of cutaneous leishmaniasis in Ecuador. American Journal of Tropical Medicine and Hygiene 48(5): 707-715, 1993

Inbred mice as model hosts for cutaneous leishmaniasis 1. resistance and susceptibility to infection with leishmania braziliensis leishmania mexicana and leishmania aethiopica. Annals of Tropical Medicine and Parasitology 78(1): 25-34, 1984

Tissue eosinophilia and Leishmania mexicana mexicana eosinophil interactions in murine cutaneous leishmaniasis. Parasite Immunology 6(5): 397-408, 1984

Cutaneous leishmaniasis in Amazonia. Report of the 1st human case of mixed infection, determined by 2 different Leishmania species: Leishmania brasiliensis and Leishmania mexicana amazonensis. Revista do Instituto de Medicina Tropical de Sao Paulo 26(5): 272-275, 1984

Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study. Journal of the American Academy of Dermatology 29(3): 443-446, 1993

In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis. Journal of Pharmacy and Pharmacology 58(8): 1043-1054, 2006

Localized cutaneous leishmaniasis (chiclero's ulcer) in Mexico: sensitivity and specificity of ELISA for IgG antibodies to Leishmania mexicana mexicana. Transactions of the Royal Society of Tropical Medicine and Hygiene 84(3): 356-258, 1990

Inefficacy of the association N-methyl glucamine and topical miltefosine in the treatment of experimental cutaneous leishmaniasis by Leishmania (Leishmania) amazonensis. Journal of Venomous Animals and Toxins including Tropical Diseases 13(3): 598-606, 2007